Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 22% ± 3% |
Insufficient scRNA-seq data for expression of TMEM250 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2841.05 | 1445 / 1445 | 100% | 61.29 | 183 / 183 |
ovary | 100% | 1736.02 | 180 / 180 | 100% | 46.37 | 430 / 430 |
uterus | 100% | 2071.86 | 170 / 170 | 100% | 66.29 | 459 / 459 |
brain | 100% | 2238.77 | 2638 / 2642 | 100% | 40.57 | 705 / 705 |
thymus | 100% | 1660.58 | 653 / 653 | 100% | 38.55 | 604 / 605 |
liver | 100% | 1561.44 | 226 / 226 | 100% | 32.93 | 405 / 406 |
intestine | 100% | 2657.65 | 966 / 966 | 100% | 63.84 | 525 / 527 |
skin | 100% | 2831.49 | 1809 / 1809 | 100% | 52.86 | 470 / 472 |
prostate | 100% | 2152.85 | 245 / 245 | 99% | 48.57 | 499 / 502 |
stomach | 100% | 1730.29 | 358 / 359 | 100% | 59.19 | 285 / 286 |
breast | 100% | 1947.21 | 459 / 459 | 99% | 46.15 | 1110 / 1118 |
kidney | 100% | 1876.92 | 89 / 89 | 99% | 31.96 | 894 / 901 |
lung | 99% | 1929.72 | 575 / 578 | 100% | 49.14 | 1150 / 1155 |
adrenal gland | 100% | 1836.88 | 258 / 258 | 99% | 33.18 | 227 / 230 |
pancreas | 98% | 1042.83 | 323 / 328 | 100% | 48.47 | 178 / 178 |
bladder | 100% | 2736.38 | 21 / 21 | 98% | 56.46 | 496 / 504 |
adipose | 100% | 2069.42 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 72.29 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 47.03 | 29 / 29 |
muscle | 100% | 2046.67 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2291.99 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 78.37 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.71 | 1 / 1 |
blood vessel | 100% | 1847.92 | 1329 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1327.01 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 1697.25 | 846 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060271 | Biological process | cilium assembly |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0008104 | Biological process | protein localization |
GO_0061640 | Biological process | cytoskeleton-dependent cytokinesis |
GO_0048524 | Biological process | positive regulation of viral process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0032153 | Cellular component | cell division site |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0031105 | Cellular component | septin complex |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005940 | Cellular component | septin ring |
GO_0005634 | Cellular component | nucleus |
GO_0003924 | Molecular function | GTPase activity |
GO_0005515 | Molecular function | protein binding |
GO_0060090 | Molecular function | molecular adaptor activity |
Gene name | TMEM250 |
Protein name | Alternative protein C9orf69 Transmembrane protein 250 (Herpes virus UL25-binding protein) Transmembrane protein 250 |
Synonyms | C9orf69 |
Description | FUNCTION: May play a role in cell proliferation by promoting progression into S phase. .; FUNCTION: (Microbial infection) Promotes human herpes simplex virus 1/HHV-1 proliferation. . |
Accessions | H3BQM9 ENST00000448040.2 ENST00000561457.2 L0R831 ENST00000557985.2 ENST00000418388.6 H0YL14 ENST00000447934.1 H3BVA3 |